• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组细菌疫苗载体的最新进展。

Recent advances with recombinant bacterial vaccine vectors.

作者信息

Shata M T, Stevceva L, Agwale S, Lewis G K, Hone D M

机构信息

Division of Vaccine Research, Institute of Human Virology, 725 Lombard Street, Baltimore, MD 21201, USA.

出版信息

Mol Med Today. 2000 Feb;6(2):66-71. doi: 10.1016/s1357-4310(99)01633-0.

DOI:10.1016/s1357-4310(99)01633-0
PMID:10652479
Abstract

Bacille Calmette-Guerin (BCG), Listeria monocytogenes, Salmonellae and Shigellae have shown promise as vaccine vectors in experimental animal models. Although disappointing results in humans and non-human primates stalled the development of this vaccination strategy, interest in this approach was reinvigorated recently by the development of bacterial DNA-vaccine-vectors. The purpose of this review is to highlight the strengths and weaknesses of bacterial vaccine vectors, and to discuss the future prospects of these vaccine delivery systems.

摘要

卡介苗(BCG)、单核细胞增生李斯特菌、沙门氏菌和志贺氏菌在实验动物模型中已显示出作为疫苗载体的潜力。尽管在人类和非人类灵长类动物中取得的令人失望的结果使这种疫苗接种策略的发展陷入停滞,但最近细菌DNA疫苗载体的开发重新激发了人们对这种方法的兴趣。这篇综述的目的是突出细菌疫苗载体的优缺点,并讨论这些疫苗递送系统的未来前景。

相似文献

1
Recent advances with recombinant bacterial vaccine vectors.重组细菌疫苗载体的最新进展。
Mol Med Today. 2000 Feb;6(2):66-71. doi: 10.1016/s1357-4310(99)01633-0.
2
Advances in the development of bacterial vector technology.细菌载体技术的发展进展。
Expert Rev Vaccines. 2003 Feb;2(1):31-43. doi: 10.1586/14760584.2.1.31.
3
An overview of vaccine vectors.疫苗载体概述。
Dev Biol Stand. 1995;84:23-32.
4
Attenuated salmonella and Shigella as carriers for DNA vaccines.减毒沙门氏菌和志贺氏菌作为DNA疫苗的载体
J Drug Target. 2003;11(8-10):481-8. doi: 10.1080/10611860410001670053.
5
Listeria as a vaccine vector.作为疫苗载体的李斯特菌。
Microbes Infect. 2007 Aug;9(10):1226-35. doi: 10.1016/j.micinf.2007.05.010. Epub 2007 May 7.
6
Salmonellae as oral vaccine carriers.沙门氏菌作为口服疫苗载体。
Dev Biol Stand. 1995;84:245-53.
7
Bacterial systems for the delivery of eukaryotic antigen expression vectors.用于递送真核抗原表达载体的细菌系统。
Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):391-9. doi: 10.1089/oli.1.2000.10.391.
8
Recent advances in the development of live, attenuated bacterial vectors.减毒活细菌载体开发的最新进展。
Curr Opin Mol Ther. 2005 Feb;7(1):62-72.
9
Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.基于重组牛分枝杆菌卡介苗的新型疫苗接种策略。
Int J Med Microbiol. 2003 Feb;292(7-8):441-51. doi: 10.1078/1438-4221-00227.
10
Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.用于易位融合蛋白的携带染色体表达盒的沙门氏菌活疫苗的评估。
Vaccine. 2009 Jun 8;27(28):3780-7. doi: 10.1016/j.vaccine.2009.03.053. Epub 2009 Apr 8.

引用本文的文献

1
Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches.结直肠癌治疗的新兴前沿领域:从靶向分子到免疫调节突破及基于细胞的方法。
Dig Dis Sci. 2025 Mar;70(3):919-942. doi: 10.1007/s10620-024-08774-2. Epub 2025 Jan 27.
2
Genetic engineering of spp. for novel vaccine strategies and therapeutics.用于新型疫苗策略和治疗方法的[物种名称]基因工程。 (注:原文中“spp.”指代不明,这里保留原文形式翻译)
EcoSal Plus. 2024 Dec 12;12(1):eesp00042023. doi: 10.1128/ecosalplus.esp-0004-2023. Epub 2024 Jul 18.
3
Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment.
针对实体瘤的 NY-ESO-1 癌症疫苗的最新进展。
Front Immunol. 2023 Sep 5;14:1255799. doi: 10.3389/fimmu.2023.1255799. eCollection 2023.
4
An mRNA-Based Multiple Antigenic Gene Expression System Delivered by Engineered for Severe Fever with Thrombocytopenia Syndrome and Assessment of Its Immunogenicity and Protection Using a Human DC-SIGN-Transduced Mouse Model.一种基于mRNA的多抗原基因表达系统,通过工程化方式递送用于严重发热伴血小板减少综合征,并使用人DC-SIGN转导小鼠模型评估其免疫原性和保护作用。
Pharmaceutics. 2023 Apr 26;15(5):1339. doi: 10.3390/pharmaceutics15051339.
5
Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.基因疫苗设计中纳米与微米尺度载体 - 细胞相互作用界面的生物材料
J Mater Chem B. 2014;46:8053-8068. doi: 10.1039/C4TB01058B. Epub 2014 Sep 12.
6
Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.活细菌载体——一种有前景的DNA疫苗递送系统。
Med Sci (Basel). 2018 Mar 23;6(2):27. doi: 10.3390/medsci6020027.
7
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.活减细菌性载体:疫苗和治疗剂传递工具。
Vaccines (Basel). 2015 Nov 10;3(4):940-72. doi: 10.3390/vaccines3040940.
8
In Vivo Programmed Gene Expression Based on Artificial Quorum Networks.基于人工群体感应网络的体内程序化基因表达
Appl Environ Microbiol. 2015 Aug;81(15):4984-92. doi: 10.1128/AEM.01113-15. Epub 2015 May 15.
9
Live bacterial vaccine vectors: an overview.活细菌疫苗载体:概述
Braz J Microbiol. 2015 Mar 4;45(4):1117-29. doi: 10.1590/s1517-83822014000400001. eCollection 2014.
10
HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model.人乳头瘤病毒16型L1减毒志贺氏菌重组疫苗在豚鼠模型中诱导了强烈的阴道和全身免疫反应。
Hum Vaccin Immunother. 2014;10(12):3491-8. doi: 10.4161/hv.36084.